These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37029745)

  • 21.
    Basyte-Bacevice V; Skieceviciene J; Valantiene I; Sumskiene J; Petrenkiene V; Kondrackiene J; Petrauskas D; Lammert F; Kupcinskas J
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD (OPERA study).
    Käräjämäki AJ; Hukkanen J; Kauma H; Kesäniemi YA; Ukkola O
    Scand J Clin Lab Invest; 2020; 80(2):106-113. PubMed ID: 31851849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese Youth.
    Umano GR; Caprio S; Di Sessa A; Chalasani N; Dykas DJ; Pierpont B; Bale AE; Santoro N
    Am J Gastroenterol; 2018 Mar; 113(3):376-383. PubMed ID: 29485130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver fat accumulation more than fibrosis causes early liver dynamic dysfunction in patients with non-alcoholic fatty liver disease.
    Di Ciaula A; Shanmugam H; Ribeiro R; Pina A; Andrade R; Bonfrate L; Raposo JF; Macedo MP; Portincasa P
    Eur J Intern Med; 2023 Jan; 107():52-59. PubMed ID: 36344354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic predisposition in metabolic-dysfunction-associated fatty liver disease and cardiovascular outcomes-Systematic review.
    Ismaiel A; Dumitrascu DL
    Eur J Clin Invest; 2020 Oct; 50(10):e13331. PubMed ID: 32589269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variants associated with steatohepatitis and liver fibrosis in HIV-infected patients with NAFLD.
    Busca C; Arias P; Sánchez-Conde M; Rico M; Montejano R; Martín-Carbonero L; Valencia E; Moreno V; Bernardino JI; Olveira A; Abadía M; González-García J; Montes ML
    Front Pharmacol; 2022; 13():905126. PubMed ID: 36110512
    [No Abstract]   [Full Text] [Related]  

  • 27. Obesity-linked suppression of membrane-bound
    Helsley RN; Varadharajan V; Brown AL; Gromovsky AD; Schugar RC; Ramachandiran I; Fung K; Kabbany MN; Banerjee R; Neumann CK; Finney C; Pathak P; Orabi D; Osborn LJ; Massey W; Zhang R; Kadam A; Sansbury BE; Pan C; Sacks J; Lee RG; Crooke RM; Graham MJ; Lemieux ME; Gogonea V; Kirwan JP; Allende DS; Civelek M; Fox PL; Rudel LL; Lusis AJ; Spite M; Brown JM
    Elife; 2019 Oct; 8():. PubMed ID: 31621579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membrane-bound O-acyltransferase 7 (MBOAT7)-driven phosphatidylinositol remodeling in advanced liver disease.
    Varadharajan V; Massey WJ; Brown JM
    J Lipid Res; 2022 Jul; 63(7):100234. PubMed ID: 35636492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MBOAT7 in liver and extrahepatic diseases.
    Caddeo A; Spagnuolo R; Maurotti S
    Liver Int; 2023 Nov; 43(11):2351-2364. PubMed ID: 37605540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of MBOAT7 gene variant with plasma ALT levels in children: the PANIC study.
    Viitasalo A; Eloranta AM; Atalay M; Romeo S; Pihlajamäki J; Lakka TA
    Pediatr Res; 2016 Nov; 80(5):651-655. PubMed ID: 27411039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 13C-Methacetin Breath Testing in Patients with Non-Alcoholic Fatty Liver Disease.
    Kempiński R; Neubauer K; Wieczorek S; Dudkowiak R; Jasińska M; Poniewierka E
    Adv Clin Exp Med; 2016; 25(1):77-81. PubMed ID: 26935501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests.
    Di Ciaula A; Calamita G; Shanmugam H; Khalil M; Bonfrate L; Wang DQ; Baffy G; Portincasa P
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The MBOAT7 rs641738 variant is associated with an improved outcome in primary sclerosing cholangitis.
    Freund C; Wahlers A; Begli NH; Leopold Y; Klöters-Plachky P; Mehrabi A; Mohr I; Sander J; Rupp C; Gotthardt DN; Weiss KH
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):646-652. PubMed ID: 31928970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined use of Genetic Polymorphisms and Elastographic Techniques in NAFLD: Fact or Fiction?
    Lombardi R; Fargion S; Fracanzani AL
    Curr Pharm Des; 2020; 26(10):1010-1018. PubMed ID: 31755380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of MBOAT7 variant on hepatitis B and C infections in Moroccan patients.
    Ezzikouri S; Elfihry R; Chihab H; Elmessaoudi-Idrissi M; Zaidane I; Jadid FZ; Karami A; Tahiri M; Elhabazi A; Kabine M; Chair M; Pineau P; Benjelloun S
    Sci Rep; 2018 Aug; 8(1):12247. PubMed ID: 30116012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy.
    Di Costanzo A; Belardinilli F; Bailetti D; Sponziello M; D'Erasmo L; Polimeni L; Baratta F; Pastori D; Ceci F; Montali A; Girelli G; De Masi B; Angeloni A; Giannini G; Del Ben M; Angelico F; Arca M
    Sci Rep; 2018 Feb; 8(1):3702. PubMed ID: 29487372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between a Polymorphism in MBOAT7 and Chronic Kidney Disease in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease.
    Koo BK; An JN; Joo SK; Kim D; Lee S; Bae JM; Park JH; Kim JH; Chang MS; Kim W
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2837-2839.e2. PubMed ID: 31546054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of GCKR and MBOAT7 genetic polymorphisms with non-alcoholic fatty liver disease.
    Chavan SU; Rathi P; Mandot A
    Clin Exp Hepatol; 2024 Mar; 10(1):39-46. PubMed ID: 38765903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane-bound
    Varadharajan V; Ramachandiran I; Massey WJ; Jain R; Banerjee R; Horak AJ; McMullen MR; Huang E; Bellar A; Lorkowski SW; Gulshan K; Helsley RN; James I; Pathak V; Dasarathy J; Welch N; Dasarathy S; Streem D; Reizes O; Allende DS; Smith JD; Simcox J; Nagy LE; Brown JM
    Elife; 2024 Apr; 12():. PubMed ID: 38648183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD.
    Meroni M; Longo M; Fracanzani AL; Dongiovanni P
    EBioMedicine; 2020 Jul; 57():102866. PubMed ID: 32629394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.